Creatinine renal clearance increased
(UMLS:C0919713)
- UMLS ID:
- C0919713
- MeSH ID:
- N/A
Synonym(s)
1.
Creatinine renal clearance increased
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Canagliflozin | FAERS: 18 | US FAERS | |
| 2 | Sitagliptin Phosphate | FAERS: 13 | OFFSIDES US FAERS | |
| 3 | Choline fenofibrate | FAERS: 9 | US FAERS | |
| 4 | Lenalidomide | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | LCZ 696 | FAERS: 6 | US FAERS | |
| 6 | Rivaroxaban | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Dabigatran | FAERS: 5 | US FAERS | |
| 8 | Deferasirox | FAERS: 5 | US FAERS | |
| 9 | empagliflozin | FAERS: 5 | US FAERS | |
| 10 | Pregabalin | FAERS: 4 | US FAERS | |
| 11 | Telmisartan | FAERS: 4 | US FAERS | |
| 12 | Teriparatide | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | Exenatide | FAERS: 3 | US FAERS | |
| 14 | Fenofibrate | FAERS: 3 | US FAERS | |
| 15 | Kombiglyze XR | FAERS: 3 | US FAERS | |
| 16 | Linagliptin | FAERS: 3 | US FAERS | |
| 17 | Sunitinib | FAERS: 3 | OFFSIDES US FAERS | |
| 18 | gemcitabine | FAERS: 3 | US FAERS | |
| 19 | telaprevir | FAERS: 3 | US FAERS | |
| 20 | 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol | FAERS: 2 | US FAERS | |
| 21 | Allopurinol | FAERS: 2 | US FAERS | |
| 22 | Bendamustine Hydrochloride | FAERS: 2 | US FAERS | |
| 23 | Capecitabine | FAERS: 2 | US FAERS | |
| 24 | Carbavance | FAERS: 2 | US FAERS | |
| 25 | Celecoxib | FAERS: 2 | US FAERS | |
| 26 | Cyclosporine | FAERS: 2 | US FAERS | |
| 27 | Pemetrexed | FAERS: 2 | US FAERS | |
| 28 | Rosuvastatin Calcium | FAERS: 2 | US FAERS | |
| 29 | Valsartan | FAERS: 2 | US FAERS | |
| 30 | Varenicline | FAERS: 2 | US FAERS | |
| 31 | edoxaban | FAERS: 2 | US FAERS | |
| 32 | entecavir | FAERS: 2 | US FAERS | |
| 33 | pirfenidone | FAERS: 2 | US FAERS | |
| 34 | Albuterol | FAERS: 1 | US FAERS | |
| 35 | Arsenic Trioxide | FAERS: 1 | US FAERS | |
| 36 | Atomoxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 37 | Atorvastatin | FAERS: 1 | US FAERS | |
| 38 | CID 129626832 | FAERS: 1 | US FAERS | |
| 39 | Clopidogrel | FAERS: 1 | US FAERS | |
| 40 | Dasatinib | FAERS: 1 | US FAERS | |
| 41 | Dronedarone hydrochloride | FAERS: 1 | US FAERS | |
| 42 | Dronedarone | FAERS: 1 | US FAERS | |
| 43 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 44 | Enfuvirtide | FAERS: 1 | US FAERS | |
| 45 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 46 | Ertapenem | FAERS: 1 | US FAERS | |
| 47 | Etodolac | FAERS: 1 | US FAERS | |
| 48 | Everolimus | FAERS: 1 | US FAERS | |
| 49 | Fondaparinux | FAERS: 1 | US FAERS | |
| 50 | Glucovance | FAERS: 1 | US FAERS | |
| 51 | Hydralazine | FAERS: 1 | US FAERS | |
| 52 | Hydrochlorothiazide | FAERS: 1 | US FAERS | |
| 53 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 54 | Isotretinoin | FAERS: 1 | US FAERS | |
| 55 | Liraglutide | FAERS: 1 | US FAERS | |
| 56 | Lithium Carbonate | FAERS: 1 | US FAERS | |
| 57 | Losartan | FAERS: 1 | US FAERS | |
| 58 | Mefloquine | FAERS: 1 | US FAERS | |
| 59 | Memantine | FAERS: 1 | US FAERS | |
| 60 | Metformin | FAERS: 1 | US FAERS | |
| 61 | Milnacipran | FAERS: 1 | US FAERS | |
| 62 | Niacin | FAERS: 1 | US FAERS | |
| 63 | Olanzapine | FAERS: 1 | US FAERS | |
| 64 | Olmesartan Medoxomil | FAERS: 1 | US FAERS | |
| 65 | Omeprazole | FAERS: 1 | US FAERS | |
| 66 | Oseltamivir | FAERS: 1 | US FAERS | |
| 67 | Perindopril | FAERS: 1 | US FAERS | |
| 68 | Ranolazine | FAERS: 1 | US FAERS | |
| 69 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 70 | Sulfasalazine | FAERS: 1 | US FAERS | |
| 71 | Tenofovir | FAERS: 1 | US FAERS | |
| 72 | Testosterone | FAERS: 1 | US FAERS | |
| 73 | Ticagrelor | FAERS: 1 | US FAERS | |
| 74 | Tigecycline | FAERS: 1 | US FAERS | |
| 75 | Tinzaparin | FAERS: 1 | US FAERS | |
| 76 | Triumeq | FAERS: 1 | US FAERS | |
| 77 | Varenicline | FAERS: 1 | US FAERS | |
| 78 | Zoledronic Acid | FAERS: 1 | OFFSIDES US FAERS | |
| 79 | apixaban | FAERS: 1 | US FAERS | |
| 80 | apremilast | FAERS: 1 | US FAERS | |
| 81 | bosutinib | FAERS: 1 | US FAERS | |
| 82 | carfilzomib | FAERS: 1 | US FAERS | |
| 83 | ceftaroline fosamil | FAERS: 1 | US FAERS | |
| 84 | dofetilide | FAERS: 1 | OFFSIDES US FAERS | |
| 85 | elbasvir-grazoprevir drug combination | FAERS: 1 | US FAERS | |
| 86 | eltrombopag | FAERS: 1 | US FAERS | |
| 87 | eltrombopag | FAERS: 1 | US FAERS | |
| 88 | fesoterodine | FAERS: 1 | US FAERS | |
| 89 | linaclotide | FAERS: 1 | US FAERS | |
| 90 | palbociclib | FAERS: 1 | US FAERS | |
| 91 | rucaparib | FAERS: 1 | US FAERS | |
| 92 | saxagliptin | FAERS: 1 | US FAERS | |
| 93 | valdecoxib | FAERS: 1 | US FAERS | |
| 94 | venetoclax | FAERS: 1 | US FAERS | |
| 95 | Ampicillin | OFFSIDES | ||
| 96 | Beclomethasone | OFFSIDES | ||
| 97 | Fludrocortisone | OFFSIDES | ||
| 98 | Formoterol Fumarate | OFFSIDES | ||
| 99 | Fulvestrant | OFFSIDES | ||
| 100 | Gentamicins | OFFSIDES | ||
| 101 | Guanfacine | OFFSIDES | ||
| 102 | Itraconazole | OFFSIDES | ||
| 103 | Lapatinib | OFFSIDES | ||
| 104 | Leflunomide | OFFSIDES | ||
| 105 | Linsidomine | OFFSIDES | ||
| 106 | Noctran | OFFSIDES | ||
| 107 | Pentoxifylline | OFFSIDES | ||
| 108 | Potassium | OFFSIDES | ||
| 109 | Pravastatin | OFFSIDES | ||
| 110 | Rocuronium | OFFSIDES | ||
| 111 | Sevoflurane | OFFSIDES | ||
| 112 | Sunitinib | OFFSIDES | ||
| 113 | Timolol | OFFSIDES | ||
| 114 | Zidovudine | OFFSIDES | ||
| 115 | aliskiren | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 116 | atovaquone, proguanil drug combination | OFFSIDES | ||
| 117 | benidipine | OFFSIDES | ||
| 118 | dexamethasone acetate | OFFSIDES | ||
| 119 | repaglinide | OFFSIDES | ||
| 120 | tegaserod | OFFSIDES | ||
| 121 | tegaserod | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.